Value of recombinant human thyrotropin in high-dose radioiodine therapy: A case report

Journal of Nuclear Medicine Technology

Volumn 30, Issue 4, 2002, Pages 185-188

  Müller, Vika ^a   Bohuslavizki, Karl H ^a,b   Klutmann, Susanne ^a   Clausen, Malte ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Nuklearmedizin Spitalerhof   (Germany)

Author keywords

Differentiated thyroid carcinoma; PET; Radioiodine therapy; Recombinant human thyrotropin

Indexed keywords

LITHIUM CARBONATE; PREDNISOLONE; RECOMBINANT THYROTROPIN; THYROXINE; THYROXINE I 131;

ADULT; ARTICLE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; NODULAR GOITER; PARALYSIS; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIOISOTOPE THERAPY; SPINAL CORD COMPRESSION; SPINE METASTASIS; SUBTOTAL THYROIDECTOMY; THORACIC SPINE; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; RADIOPHARMACEUTICALS; RECOMBINANT PROTEINS; SPINAL NEOPLASMS; THORACIC VERTEBRAE; THYROID NEOPLASMS; THYROTROPIN;

EID: 0036897559     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McDougall IR, Weigel RJ. Recombinant human thyrotropin in the management of thyroid cancer. Curr Opin Oncol. 2001;13:39-43.
2. 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. J Clin Endocrinol Metab. 1996;81:1724-1725.
3. Reiners C, Luster M, Lassmann M. Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): Whole-body scanning with iodine-131. J Endocrinol Invest. 1999;22(suppl):17-24.
4. Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM. Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: Case report and review literature. Endocr Pract. 2000;6:460-464.
5. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab. 1999;84:3877-3885.
6. Ladenson PW. Recombinant thyrotropin versus thyroid hormone withdrawal in evaluating patients with thyroid carcinoma. Semin Nucl Med. 2000;30:98-106.
7. Meier CA, Braverman LE, Ebner SA, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab. 1994;78:188-196.
8. Risse JH, Grunwald F, Bender H, Schuller H, Van Roost D, Biersack HJ. Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis. Thyroid. 1999;9:1253-1256.
9. Lippi F, Capezzone M, Angelini F, et al. Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol. 2001;144:5-11.
10. Perros P. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: Preliminary therapeutic experience. J Endocrinol Invest. 1999;22(suppl):30-34.
11. Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2000;85:3640-3645.
12. Ramirez L, Braverman LE, White B, Emerson CH. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab. 1997;82:2836-2839.
13. Mariani G, Ferdeghini M, Augeri C, et al. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. Cancer Biother Radiopharm. 2000;15:211-217.
14. Feine U, Lietzenmeyer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996;37:1468-1472.
15. Boehm TM, Burman KD, Barnes S, Wartofsky L. Lithium and iodine combination therapy for thyrotoxicosis. Acta Endocrinol (Copenh). 1980; 94:174-183.
16. Lazarus JH, Richards AR, Addison GM, Owen GM. Treatment of thyrotoxicosis with lithium carbonate. Lancet. 1974;2:1160-1163.
17. Spaulding SW, Burrow GN, Bermudez F, Himmelhoch JM. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metab. 1972;35:905-911.
18. Pons F, Carrio I, Estorch M, et al. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma. Clin Nucl Med. 1987;8:644-647.